Literature DB >> 8938691

Outcome of commercial renal transplantation: two years follow-up.

H Mansy1, A Khalil, T F Aly, P Filobbos, S al-Dusari, Z al-Shareef, S Shlash.   

Abstract

The results of living non-related renal transplants from India involving unethical exploitation of the donor are inferior. We followed-up 12 patients from our unit who went to a center in Bombay for renal transplantation and compared the results with our local new renal transplant programme. Two-year graft survival was 70% compared to 88% with our new renal transplant program. Also, we emphasised the human side of the problem. We addressed the problem of shortages of organ donation locally because failure to obtain consent from relatives and the need for intensive public education is required to overcome this problem. Finally, Islamic principles and rules that are related to organ transplantation have been discussed in detail, and the main purpose is to enlighten the Western reader.

Entities:  

Mesh:

Year:  1996        PMID: 8938691     DOI: 10.1159/000189462

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  4 in total

1.  Living unrelated-commercial-kidney transplantation: when there is no chance to survive.

Authors:  Mehmet Sukru Sever
Journal:  Pediatr Nephrol       Date:  2006-06-30       Impact factor: 3.714

2.  Commercial living non-related organ transplantation: a viewpoint from a developed country.

Authors:  Peter F Hoyer
Journal:  Pediatr Nephrol       Date:  2006-06-30       Impact factor: 3.714

3.  Pediatric Renal Transplantation in Oman: A Single-center Experience.

Authors:  Mohamed S Al Riyami; Sulaiman Al Saidi; Badria Al Ghaithi; Anisa Al Maskari; Sadiq Lala; Nabil Mohsin; Lekha Hirshikesan; Naifain Al Kalbani
Journal:  Oman Med J       Date:  2018-01

4.  Commercial Kidney Transplantation: Attitude, Knowledge, Perception, and Experience of Recipients.

Authors:  Fatma Al Rahbi; Issa Al Salmi
Journal:  Kidney Int Rep       Date:  2017-02-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.